RxDoctor Payments Data

Arriyan Dowlatshahi, MD

Surgery of the Hand · Boston, MANPI 1124331061

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (51.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Kairos Surgical Inc at 47.8% of the total. Reporting peaked in 2021 at $1,344 and has fallen 70.3% since, to $399 in 2025.

$2,566in general payments, 2019–2025

Across 19 payments — averaging $135.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kairos Surgical Inc$1K
  • Smith+Nephew$697
  • Checkpoint Surgical, Inc$133
  • Lifenet Health$124
  • Axogen$123
  • Trimed, Inc.$112
  • plus $152 from 2 others

What the payments were for

  • Travel & lodging$462%
  • Food & beverage$1,32151%
  • Education$1,20047%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,566 in reported general payments places this provider in the 65th percentile of 23 surgery of the hand providers in Massachusetts.

See all surgery of the hand providers in Massachusetts

Medicare billing

Part B allowed, 2024
$362,209
Medicare patients
608
Services billed
7,720

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl27$83

Paid to pharmacies, not to this prescriber.

Other surgery of the hand in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →